Analysis Of Income And Expense [Abstract]

Optomed Oyj - Filing #2177087

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue	14,660,000 EUR	—	—	—	14,850,000 EUR	—
Material income and expense [abstract]
Finance income (cost)	454,000 EUR	—	—	—	453,000 EUR	—
Expenses by nature [abstract]
Classes of employee benefits expense [abstract]
Employee benefits expense	8,827,000 EUR	—	—	—	8,702,000 EUR	—
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss	3,145,000 EUR	—	—	—	2,778,000 EUR	—
Other expenses, by nature	3,193,000 EUR	—	—	—	3,858,000 EUR	—
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	139,000 EUR	—	139,000 EUR	253,000 EUR	253,000 EUR	—
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	5,333,000 EUR	5,472,000 EUR	139,000 EUR	253,000 EUR	4,502,000 EUR	4,249,000 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	5,333,000 EUR	—	—	—	4,502,000 EUR	—